The prognostic significance of Ki-67 labeling indices for oligodendrogliomas

被引:86
作者
Coons, SW [1 ]
Johnson, PC [1 ]
Pearl, DK [1 ]
机构
[1] OHIO STATE UNIV,DEPT STAT,COLUMBUS,OH 43210
关键词
Ki-67; histological grade; MIB-1; oligodendroglioma; proliferation; survival;
D O I
10.1097/00006123-199710000-00021
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
OBJECTIVE: The prognostic significance of quantitative measurement of tumor proliferative activity was evaluated for oligodendroglial tumors. METHODS: Ki-67/MIB-1 immunochemistry was used to measure proliferative activity in 81 oligodendrogliomas and oligoastrocytomas. The relationships among survival, proliferation, histological features, and clinical Variables were evaluated using a Cox proportional hazards analysis. RESULTS: After stratifying by histological grade and adjusting for age at diagnosis, there was a significant association between the Ki-67/MIB-1 labeling index (LI) (percentage of positive cells) and survival (P = 0.04). This association was illustrated further by the significantly different survival of two groups based on LI ranges of less than or equal to 5 and greater than 5 (P < 0.0001). CONCLUSION: The poor correlation between mitotic figures and survival in oligodendrogliomas that has been reported previously emphasizes the need for an accurate method to measure proliferative activity. Our study demonstrated the usefulness of the Ki-67/MIB-1 LI and demonstrated that LI ranges can be defined for clinical application.
引用
收藏
页码:878 / 884
页数:7
相关论文
共 64 条
[1]   PROLIFERATING CELL NUCLEAR ANTIGEN EXPRESSION IN CENTRAL-NERVOUS-SYSTEM NEOPLASMS [J].
ALLEGRANZA, A ;
GIRLANDO, S ;
ARRIGONI, GL ;
VERONESE, S ;
MAURI, FA ;
GAMBACORTA, M ;
POLLO, B ;
DALLAPALMA, P ;
BARBARESCHI, M .
VIRCHOWS ARCHIV A-PATHOLOGICAL ANATOMY AND HISTOPATHOLOGY, 1991, 419 (05) :417-423
[2]   PROLIFERATING CELL NUCLEAR ANTIGEN EXPRESSION IN THE SURVIVAL OF ASTROCYTOMA PATIENTS [J].
ANG, LC ;
PLEWES, M ;
TAN, L ;
BEGLEY, H ;
AGRANOVICH, A ;
SHUL, D .
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1994, 21 (04) :306-310
[3]   QUANTITATIVE GROWTH FRACTION EVALUATION WITH MIBI AND KI67 ANTIBODIES IN BREAST CARCINOMAS [J].
BARBARESCHI, M ;
GIRLANDO, S ;
MAURI, FM ;
FORTI, S ;
ECCHER, C ;
MAURI, FA ;
TOGNI, R ;
DALLAPALMA, P ;
DOGLIONI, C .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1994, 102 (02) :171-175
[4]  
BRUNER JM, 1987, SEMIN DIAGN PATHOL, V4, P251
[5]  
Burger P. C., 1991, SURGICAL PATHOLOGY N, P193
[6]  
BURGER PC, 1987, CANCER, V59, P1345, DOI 10.1002/1097-0142(19870401)59:7<1345::AID-CNCR2820590719>3.0.CO
[7]  
2-A
[8]  
BURGER PC, 1985, CANCER, V56, P1106, DOI 10.1002/1097-0142(19850901)56:5<1106::AID-CNCR2820560525>3.0.CO
[9]  
2-2
[10]   THE USE OF THE MONOCLONAL-ANTIBODY KI-67 IN THE IDENTIFICATION OF PROLIFERATING CELLS - APPLICATION TO SURGICAL NEUROPATHOLOGY [J].
BURGER, PC ;
SHIBATA, T ;
KLEIHUES, P .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1986, 10 (09) :611-617